Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-01-05 Sale | 2026-01-05 8:31 pm | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 57,661 | $32.9 | $1,896,969 | 280,891 (Direct) | View |
| 2026-01-05 Sale | 2026-01-05 8:31 pm | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 57,661 | $32.98 | $1,901,405 | 500,190 (Direct) | View |
| 2026-01-05 Sale | 2026-01-05 8:28 pm | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 233,409 | $32.96 | $7,692,121 | 2,675,591 (Direct) | View |
| 2026-01-02 Sale | 2026-01-05 8:25 pm | Viking Therapeutics Inc. | VKTX | FOEHR MATTHEW W Director | 16,000 | $35.11 | $561,694 | 155,586 (Direct) | View |
| 2025-10-28 Sale | 2025-10-28 7:51 pm | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 6,185 | $35 | $216,492 | 382,467 (Direct) | View |
| 2025-10-27 Sale | 2025-10-28 7:49 pm | Viking Therapeutics Inc. | VKTX | Rowland Charles A Jr Director | 60,000 | $35.57 | $2,134,278 | 30,000 (Direct) | View |
| 2025-10-28 Sale | 2025-10-28 7:48 pm | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 38,989 | $35.01 | $1,364,923 | 2,419,109 (Direct) | View |
| 2025-10-28 Sale | 2025-10-28 7:47 pm | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 6,185 | $35 | $216,481 | 173,592 (Direct) | View |
| 2025-07-03 Sale | 2025-07-03 3:31 pm | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 26,889 | $27.8 | $747,633 | 2,388,014 (Direct) | View |
| 2025-07-03 Sale | 2025-07-03 3:31 pm | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 4,266 | $27.76 | $118,428 | 168,660 (Direct) | View |
| 2025-07-03 Sale | 2025-07-03 3:30 pm | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 4,266 | $27.77 | $118,473 | 377,535 (Direct) | View |
| 2025-03-31 Purchase(A) | 2025-04-08 7:05 pm | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 1,240 | $24.15 | $29,943 | 1,240 (Direct) | View |
| 2025-03-31 Purchase | 2025-04-02 6:29 pm | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 1,240 | $24.15 | $29,943 | 1,240 (Direct) | View |
| 2025-01-06 Sale | 2025-01-06 8:16 pm | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 194,490 | $42.75 | $8,313,601 | 2,444,870 (Direct) | View |
| 2025-01-06 Sale | 2025-01-06 8:15 pm | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 54,215 | $42.75 | $2,317,599 | 411,334 (Direct) | View |
| 2025-01-06 Sale | 2025-01-06 8:14 pm | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 50,309 | $42.75 | $2,150,595 | 202,459 (Direct) | View |
| 2024-11-08 Sale | 2024-11-08 6:22 pm | Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director | 2,000 | $68.67 | $137,333 | 67,965 (Direct) | View |
| 2024-10-28 Sale | 2024-10-28 9:48 pm | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 131,687 | $76.61 | $10,089,164 | 302,366 (Direct) | View |
| 2024-10-25 Sale | 2024-10-25 7:28 pm | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 11,000 | $80.89 | $889,790 | 11,000 (Direct) | View |
| 2024-10-25 Sale | 2024-10-25 7:27 pm | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 16,000 | $79.5 | $1,272,000 | 9,500 (Direct) | View |
| 2024-09-20 Sale | 2024-09-20 9:21 pm | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 10,300 | $69.5 | $715,850 | 9,500 (Direct) | View |
| 2024-09-20 Sale | 2024-09-20 9:20 pm | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 216,130 | $70.83 | $15,308,553 | 2,369,927 (Direct) | View |
| 2024-08-21 Sale | 2024-08-22 7:23 pm | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 1,000 | $69.9 | $69,900 | 2,586,057 (Direct) | View |
| 2024-08-21 Sale | 2024-08-22 7:23 pm | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 5,700 | $69.72 | $397,430 | 19,800 (Direct) | View |
| 2024-08-19 Sale | 2024-08-19 8:13 pm | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 112,870 | $65.8 | $7,426,508 | 2,587,057 (Direct) | View |
| 2024-08-19 Sale | 2024-08-19 8:11 pm | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 16,000 | $62.22 | $995,453 | 9,500 (Direct) | View |
| 2024-08-14 Sale | 2024-08-14 8:03 pm | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 20,786 | $57.53 | $1,195,736 | 9,500 (Direct) | View |
| 2024-07-30 Sale | 2024-07-31 4:05 pm | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 16,136 | $57.15 | $922,212 | 187,052 (Direct) | View |
| 2024-07-30 Sale | 2024-07-31 4:05 pm | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 115,859 | $57.58 | $6,670,604 | 2,354,927 (Direct) | View |
| 2024-07-30 Sale | 2024-07-31 4:05 pm | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 18,026 | $57.13 | $1,029,912 | 362,149 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-01-02 Option Award | 2026-01-05 8:31 pm | N/A 2036-01-02 | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 164,049 | $0 | 280,891 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-05 8:31 pm | N/A 2036-01-02 | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 164,049 | $0 | 500,190 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-05 8:28 pm | N/A 2036-01-02 | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 478,780 | $0 | 2,675,591 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-05 8:26 pm | 2027-01-02 2036-01-02 | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 23,550 | $0 | 33,050 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-05 8:26 pm | 2027-01-02 2036-01-02 | Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director | 23,550 | $0 | 71,515 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-05 8:25 pm | 2027-01-02 2036-01-02 | Viking Therapeutics Inc. | VKTX | Rowland Charles A Jr Director | 23,550 | $0 | 53,550 (Direct) | View |
| 2026-01-02 Exercise | 2026-01-05 8:25 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | FOEHR MATTHEW W Director | 16,000 | $3.33 | 155,586 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-05 8:25 pm | 2027-01-02 2036-01-02 | Viking Therapeutics Inc. | VKTX | FOEHR MATTHEW W Director | 23,550 | $0 | 155,586 (Direct) | View |
| 2026-01-02 Exercise | 2026-01-05 8:25 pm | 2017-01-04 2026-01-04 | Viking Therapeutics Inc. | VKTX | FOEHR MATTHEW W Director | 16,000 | $0 | 155,586 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-05 8:24 pm | 2027-01-02 2036-01-02 | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 23,550 | $0 | 24,790 (Direct) | View |
| 2025-10-27 Option Award | 2025-10-28 7:51 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 11,117 | $0 | 382,467 (Direct) | View |
| 2025-10-27 Option Award | 2025-10-28 7:49 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Rowland Charles A Jr Director | 22,000 | $5.8 | 30,000 (Direct) | View |
| 2025-10-27 Option Award | 2025-10-28 7:49 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Rowland Charles A Jr Director | 22,000 | $4.88 | 30,000 (Direct) | View |
| 2025-10-27 Exercise | 2025-10-28 7:49 pm | 2019-01-02 2028-01-02 | Viking Therapeutics Inc. | VKTX | Rowland Charles A Jr Director | 60,000 | $0 | 30,000 (Direct) | View |
| 2025-10-27 Option Award | 2025-10-28 7:49 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Rowland Charles A Jr Director | 16,000 | $4.48 | 30,000 (Direct) | View |
| 2025-10-27 Option Award | 2025-10-28 7:48 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 70,084 | $0 | 2,419,109 (Direct) | View |
| 2025-10-27 Option Award | 2025-10-28 7:47 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 11,117 | $0 | 173,592 (Direct) | View |
| 2025-07-02 Option Award | 2025-07-03 3:31 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 48,333 | $0 | 2,388,014 (Direct) | View |
| 2025-07-02 Option Award | 2025-07-03 3:31 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 7,667 | $0 | 168,660 (Direct) | View |
| 2025-07-02 Option Award | 2025-07-03 3:30 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 7,667 | $0 | 377,535 (Direct) | View |
| 2025-04-11 Exercise | 2025-04-14 7:26 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | FOEHR MATTHEW W Director | 20,786 | $8 | 132,036 (Direct) | View |
| 2025-04-11 Exercise | 2025-04-14 7:26 pm | 2016-05-26 2025-04-28 | Viking Therapeutics Inc. | VKTX | FOEHR MATTHEW W Director | 20,786 | $0 | 132,036 (Direct) | View |
| 2025-01-03 Option Award | 2025-01-06 8:16 pm | 2026-01-03 2035-01-03 | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 334,433 | $0 | 2,444,870 (Direct) | View |
| 2025-01-03 Option Award | 2025-01-06 8:15 pm | 2026-01-03 2035-01-03 | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 103,400 | $0 | 411,334 (Direct) | View |
| 2025-01-03 Option Award | 2025-01-06 8:14 pm | 2026-01-03 2035-01-03 | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 103,400 | $0 | 202,459 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 8:14 pm | 2026-01-02 2035-01-02 | Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director | 18,800 | $0 | 18,800 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 8:13 pm | 2026-01-02 2035-01-02 | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 18,800 | $0 | 18,800 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 8:13 pm | 2026-01-02 2035-01-02 | Viking Therapeutics Inc. | VKTX | Rowland Charles A Jr Director | 18,800 | $0 | 18,800 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 8:12 pm | 2026-01-02 2035-01-02 | Viking Therapeutics Inc. | VKTX | FOEHR MATTHEW W Director | 18,800 | $0 | 18,800 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 8:11 pm | 2026-01-02 2035-01-02 | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 18,800 | $0 | 18,800 (Direct) | View |
| 2024-11-08 Exercise | 2024-11-08 6:22 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director | 2,000 | $5.8 | 67,965 (Direct) | View |
| 2024-11-08 Exercise | 2024-11-08 6:22 pm | 2022-01-04 2031-01-04 | Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director | 2,000 | $0 | 67,965 (Direct) | View |
| 2024-10-28 Exercise | 2024-10-28 9:48 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 26,000 | $5.8 | 302,366 (Direct) | View |
| 2024-10-28 Exercise | 2024-10-28 9:48 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 51,000 | $8.52 | 302,366 (Direct) | View |
| 2024-10-28 Exercise | 2024-10-28 9:48 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 4,251 | $4.68 | 302,366 (Direct) | View |
| 2024-10-28 Exercise | 2024-10-28 9:48 pm | 2021-01-03 2030-01-03 | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 94,001 | $0 | 302,366 (Direct) | View |
| 2024-10-28 Exercise | 2024-10-28 9:48 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 12,750 | $7.77 | 302,366 (Direct) | View |
| 2024-10-25 Exercise | 2024-10-25 7:28 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 11,000 | $4.88 | 11,000 (Direct) | View |
| 2024-10-25 Exercise | 2024-10-25 7:28 pm | 2023-01-03 2032-01-03 | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 11,000 | $0 | 11,000 (Direct) | View |
| 2024-10-25 Exercise | 2024-10-25 7:27 pm | 2019-01-02 2028-01-02 | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 16,000 | $0 | 9,500 (Direct) | View |
| 2024-10-25 Exercise | 2024-10-25 7:27 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 16,000 | $4.48 | 9,500 (Direct) | View |
| 2024-09-20 Exercise | 2024-09-20 9:21 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 10,300 | $1.19 | 9,500 (Direct) | View |
| 2024-09-20 Exercise | 2024-09-20 9:21 pm | 2018-01-03 2027-01-03 | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 10,300 | $0 | 9,500 (Direct) | View |
| 2024-09-20 Exercise | 2024-09-20 9:20 pm | 2021-01-03 2030-01-03 | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 166,130 | $0 | 2,369,927 (Direct) | View |
| 2024-09-20 Exercise | 2024-09-20 9:20 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 166,130 | $7.77 | 2,369,927 (Direct) | View |
| 2024-08-21 Exercise | 2024-08-22 7:23 pm | 2021-01-03 2030-01-03 | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 1,000 | $0 | 2,586,057 (Direct) | View |
| 2024-08-21 Exercise | 2024-08-22 7:23 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 1,000 | $7.77 | 2,586,057 (Direct) | View |
| 2024-08-21 Exercise | 2024-08-22 7:23 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 5,700 | $1.19 | 19,800 (Direct) | View |
| 2024-08-21 Exercise | 2024-08-22 7:23 pm | 2018-01-03 2027-01-03 | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 5,700 | $0 | 19,800 (Direct) | View |
| 2024-08-19 Exercise | 2024-08-19 8:13 pm | 2021-01-03 2030-01-03 | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 112,870 | $0 | 2,587,057 (Direct) | View |
| 2024-08-19 Exercise | 2024-08-19 8:13 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 112,870 | $7.77 | 2,587,057 (Direct) | View |
| 2024-08-19 Exercise | 2024-08-19 8:11 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 16,000 | $3.33 | 9,500 (Direct) | View |
| 2024-08-19 Exercise | 2024-08-19 8:11 pm | 2017-01-04 2026-01-04 | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 16,000 | $0 | 9,500 (Direct) | View |
| 2024-08-14 Exercise | 2024-08-14 8:03 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 20,786 | $8 | 9,500 (Direct) | View |
| 2024-08-14 Exercise | 2024-08-14 8:03 pm | 2016-05-26 2025-04-28 | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 20,786 | $0 | 9,500 (Direct) | View |
| 2024-07-29 Option Award | 2024-07-31 4:05 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 28,334 | $0 | 187,052 (Direct) | View |
| 2024-07-29 Option Award | 2024-07-31 4:05 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 204,333 | $0 | 2,354,927 (Direct) | View |
| 2024-07-29 Option Award | 2024-07-31 4:05 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 31,667 | $0 | 362,149 (Direct) | View |